No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation
1.R. T. Hoppe, J. Williams, R. Warnke, D. R. Goffinet, and M. A. Bagshaw, “Carcinoma of the nasopharynx: The significance of history,” Int. J. Radiat. Oncol., Biol., Phys. 4, 199–205 (1978).
2.E. P. Zhang, P. G. Lian, K. L. Cai, Y. F. Chen, M. D. Cai, X. F. Zheng, and X. X. Guang, “Radiation therapy of nasopharyngeal cancer: Prognostic factors based on a follow up 1302 patients,” Int. J. Radiat. Oncol., Biol., Phys. 16, 301–305 (1989).
3.T. X. Lu, W. Y. Mai, B. S. Teh, Y. H. Hu, H. H. Lu, J. K. Chiu, L. S. Carpenter, S. Y. Woo, and E. B. Butler, “Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 51, 589–598 (2001).
4.W. T. Zhang, J. Y. Qian, and K. T. Chen, “The results of nasopharyngeal carcinoma treated by combined external irradiation and intracavitary brachytherapy of the high dose rate,” Chin. J. Radiat. Oncol. 5, 224–227 (1995).
5.X. P. Cao, K. T. Chen, Z. C. He, and W. T. Zhang, “Short-and long-term therapeutic effects of brachytherapy on intracavitary residual tumor in 563 nasopharyngeal carcinoma (NPC) patients,” Chin. J. Oncol. 20, 146–147 (1998).
6.P. M. Teo, M. K. Kam, S. Leung, P. H. Choi, W. Yeung, C. Leung, Y. Ngar, and W. Lee, “Adjuvant intracavitary brachytherapy significantly enhances local tumor control in early T-Stage nasopharyngeal carcinoma (NPC): The efficacy of a home-made applicator,” Int. J. Radiat. Oncol., Biol., Phys. 54 Supple. 292 (2002).
7.T. W. Leung, S. Y. Tung, W. K. Sze, W. M. Sze, V. Y. Wong, and S. K. O, “Salvage brachytherapy for patients with local persistent nasopharyngeal carcinoma,” Int. J. Radiat. Oncol., Biol., Phys. 47, 405–412 (2000).
8.J. T. Chang, L. C. See, S. G. Tang, S. P. Lee, C. C. Wang, and J. H. Hong, “The role of brachytherapy in early-stage nasopharyngeal carcinoma,” Int. J. Radiat. Oncol., Biol., Phys. 36, 1019–1024 (1996).
9.G. L. Zheng, “Mode of spread in nasopharyngeal carcinoma as seen on CT scan,” Chin. J. Oncol. 10, 293–295 (1988). (in Chinese).
10.X. P. Cao, K. T. Chen, F. Zhang, Z. C. He, S. R. Lin, and H. Q. Qing, “The technique of the individual applicator artifact for nasopharyngeal carcinoma intracavitary brachytherapy,” Cancer 18, 577 (1999). (in Chinese).
Sonzogni A (Database Manager). NuDat 2.1 www.nndc bnl. Gov/nndc/nudat
National Nuclear Data Center, Brookhaven National Laboratory, 2004.
12.X. K. Zheng, H. X. Zhang, and Y. S. Shi, “Individualized planning of intracavitory brachytherapy for nasopharyngeal carcinoma (NPC),” J. First Mil. Med. Univ. 20, 51–54 (2000). (in Chinese).
13.T. W. Leung, S. Y. Tung, V. Y. Wong, C. M. Lui, W. K. Sze, K. L. Cheung, W. H. Lau, and S. K. O, “High dose rate intracavitary brachytherapy in the treatment of nasopharyngeal carcinoma,” Acta Oncol. 35, 43–47 (1996).
14.T. W. Leung, V. Y. Wong, C. M. Lui, W. W. Tsang, W. K. Sze, and S. K. O, “The importance of three-dimensional brachytherapy treatment planning for nasopharyngeal carcinoma,” Clin. Oncol. 9, 35–40 (1997).
15.M. Ljungberg, K. Sjogreen, X. Liu, E. Frey, Y. Dewaraja, and S. E. Strand, “A 3-dimensional absorbed dose calculation method based on quantitative for evaluation for I-131 using Monte Carlo simulation,” J. Nucl. Med. 43, 1101–1109 (2002).
16.L. Jonsson, X. Liu, B. Jonsson, M. Ljungberg, and S. E. Strand, “A dosimetry model for the small intestine incorporating intestinal wall activity and cross-doses,” J. Nucl. Med. 43, 1657–1664 (2002).
18.M. J. Steggerda, L. M. F. Moonen, G. M. F. Damen, and J. V. Lebesque, “An analysis of the effect of ovoid shields in a selectron-LDR cervical applicator on dose distributions in rectum and bladder,” Int. J. Radiat. Oncol., Biol., Phys. 39, 237–245 (1997).
19.P. Teo, S. Y. Tsao, and S. F. Leung, “Afterloading intracavitary radiation treatment of nasopharyngeal carcinoma. Description of a technique and preliminary treatment results,” Acta Oncol. 28, 525–527 (1989).
20.P. Teo, S. Y. Tsao, W. Shiu, W. T. Leung, V. Tsang, P. Yu, and C. Lui, “A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong,” Int. J. Radiat. Oncol., Biol., Phys. 17, 515–530 (1989).
21.P. M. Teo, S. F. Leung, J. Fowler, T. W. Leung, Y. Tung, S. K. O, W. Y. Lee, and B. Zee, “Improved local control for early T-stage nasopharyngeal carcinoma—a tale of two hospitals,” Radiother. Oncol. 57, 155–166 (2000).
22.X. K. Zheng, L. H. Chen, Y. Q. Chen, and X. G. Deng, “Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma,” Int. J. Radiat. Oncol., Biol., Phys. 60, 165–170 (2004).
23.G. Lymperopoulou, E. Pantelis, P. Papagiannis, H. Rozaki-Mavrouli, L. Sakelliou, D. Baltas, and P. Karaiskos, “A Monte Carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set,” Med. Phys. 31, 3080–3086 (2004).
24.T. B. Tiourina, W. J. Dries, and P. M. van der Linden, “Measurements and calculations of the absorbed dose distribution around a 60Co source,” Med. Phys. 22, 549–554 (1995).
26.D. L. Larson, R. D. Lindberg, E. Lane, and H. Goepfert, “Major complications of radiotherapy in cancer of the oral cavity and oropharynx. A retrospective study,” Am. J. Surg. 146, 531–536 (1983).
27.J. W. Denham, L. J. Peters, J. Johansen, M. Poulsen, D. S. Lamb, A. Hindley, P. C. O'Brien, N. A. Spry, M. Penniment, H. Krawitz, S. Williamson, J. Bear, and L. Tripcony, “Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?” Radiother. Oncol. 52, 157–164 (1999).
28.F. Thomas, F. Ozanne, G. Mamelle, P. Wibault, and F. Eschwege, “Radiotherapy alone for oropharyngeal carcinomas: The role of fraction size ( vs ) on local control and early and late complications,” Int. J. Radiat. Oncol., Biol., Phys. 15, 1097–1102 (1988).
29.A. W. Lee, W. Foo, S. C. Law, L. J. Peters, Y. F. Poon, R. Chappell, W. M. Sze, S. Y. Tung, W. H. Lau, and J. H. Ho, “Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma,” Int. J. Radiat. Oncol., Biol., Phys. 46, 865–872 (2000).
30.T. Major, C. Polgar, J. Fodor, A. Somogyi, and G. Nemeth, “Conformality and homogeneity of dose distributions in interstitial implants at idealized target volumes: A comparison between the Paris and dose-point optimized systems,” Radiother. Oncol. 62, 103–111 (2002).
31.N. J. Slevin, J. M. Wilkinson, H. M. Filby, and N. K. Gupta, “Intracavitary radiotherapy boosting for nasopharynx cancer,” Br. J. Radiol. 70, 412–414 (1997).
32.G. H. Fletcher, “Cervical radium applicators with screening in the direction of bladder and rectum,” Radiology 60, 77–84 (1953).
33.R. Mohan, I. Y. Martel, L. L. Anderson, and D. Nori, “Measurements of radiation dose distributions for shielded cervical applicators,” Int. J. Radiat. Oncol., Biol., Phys. 11, 861–868 (1985).
34.F. Williamson and D. Holcomb, “Dose distributions produced by a shielded vaginal cylinder using a high-activity iridium-192 source,” Med. Phys. 22, 101–106 (1994).
35.J. Markman, J. F. Williamson, J. F. Dempsey, and D. A. Low, “On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats,” Med. Phys. 28, 147–155 (2001).
Article metrics loading...
Full text loading...
Most read this month